5 Pill - yellow round, 8mm
Pill with imprint 5 is Yellow, Round and has been identified as Meloxicam 7.5 mg. It is supplied by Carlsbad Technology, Inc.
Meloxicam is used in the treatment of Osteoarthritis; Juvenile Rheumatoid Arthritis; Rheumatoid Arthritis; Pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 5
Meloxicam
- Imprint
- 5
- Strength
- 7.5 mg
- Color
- Yellow
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Carlsbad Technology, Inc.
- Inactive Ingredients
-
silicon dioxide,
sodium starch glycolate type A potato,
lactose,
magnesium stearate,
microcrystalline cellulose,
povidone k30,
sodium citrate
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 42291-0597 | AvKare, Inc. |
| 61442-0126 | Carlsbad Technology, Inc. |
| 68071-0528 (Discontinued) | Nucare Pharmaceuticals Inc. (repackager) |
Related images for "5"
More about meloxicam
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (602)
- Drug images
- Latest FDA alerts (5)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Patient resources
- Meloxicam drug information
- Meloxicam (Intravenous) (Advanced Reading)
- Meloxicam Orally-Disintegrating Tablets
Other brands
Mobic, Anjeso, Vivlodex, Qmiiz ODT
Professional resources
Other brands
Mobic, Anjeso, Vivlodex, Xifyrm, Qmiiz ODT
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.